Neos Therapeutics, Inc. announced that the FDA has approved Adzenys ER (amphetamine) Extended-Release Oral Suspension. Neos Therapeutics is the only...
Eisai and Arena Pharmaceuticals have announced that the FDA has accepted for filing the New Drug Application for an extended...
Flexion Therapeutics, Inc.announced that the FDA approved Zilretta (triamcinolone acetonide extended-release injectable suspension), the first and only extended-release, intra-articular injection...
Alcobra says that top-line results from the Phase III MEASURE trial of MG01CI (metadoxine extended release) failed to show a...
Egalet Corporation has announced the company has submitted a new drug application (NDA) for Arymo ER (morphine sulfate) extended-release tablets...
Egalet Corporation announced that the FDA has accepted the new drug application (NDA) for Arymo ER (morphine sulfate) extended-release tablets....
Allergan announced that it has launched a generic version of Invega (paliperidone extended-release tablets) from Janssen in the USA. Allergan...
The FDA has approved MorphaBond (morphine sulfate extended-release) tablets, for oral use, from Inspirion Delivery Technologies. MorphaBond is an abuse-deterrent...
The FDA has accepted for review the supplemental new drug application (sNDA) for Trokendi XR (topiramate extended release), from Supernus...